| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.15 | 0.001 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.13 | 0.004 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.13 | 0.004 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.13 | 0.005 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.093 | 0.02 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.09 | 0.03 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.083 | 0.08 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.069 | 0.1 |